Optimizing A1c and TSH Test Orders with Clinical Decision Support
Evaluation of Our Practice Advisory (OPA) Interventions on Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Short Interval Ordering
This study is testing a new alert system to help doctors decide when to order blood tests for diabetes and thyroid function, aiming to reduce unnecessary repeat tests and improve patient care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 384 (estimated) |
| Sex | All |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT06993805 on ClinicalTrials.gov |
What this trial studies
This initiative evaluates the impact of a randomized Our Practice Advisory (OPA) intervention on physician ordering behavior for Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) tests. The OPA alerts providers when these tests are ordered within 30 days of a prior result, encouraging them to reconsider unnecessary repeat testing. By focusing on optimizing resource use and aligning test orders with evidence-based guidelines, the study aims to improve patient outcomes and inform broader clinical decision support strategies. The results will help determine if the OPA should be implemented across all patients and potentially extended to other laboratory tests.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have had A1c or TSH tests ordered within the prior 30 days during their inpatient or observation stays at UCLA Health System hospitals.
Not a fit: Patients who have not had a result for A1c or TSH tests ordered in the prior 30 days will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could reduce unnecessary testing and improve patient care by ensuring more appropriate test ordering.
How similar studies have performed: Other studies have shown success with similar clinical decision support interventions, indicating potential for positive outcomes in optimizing test ordering.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Inpatient or observation stays within UCLA Health System hospitals * Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) ordered, AND this lab was ordered and resulted within the prior 30 days Exclusion Criteria: * Have an A1c or TSH ordered and do not have a result for one of these labs in the prior 30 days
Where this trial is running
Los Angeles, California
- UCLA Health System — Los Angeles, California, United States (Recruiting)
Study contacts
- Study coordinator: Katelyn Clinical Research Coordinator
- Email: katenguyen@mednet.ucla.edu
- Phone: 310-267-5250
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.